To estimate how often healthcare providers asked about tobacco use and advised cessation among US adults using different tobacco products, and to examine respondent characteristics associated with these reports.
Approach:
Data: Analyses used 2021–2023 National Survey on Drug Use and Health public-use data from 139,524 adults, with survey weights.
Tobacco-use groups: Participants were classified as exclusive cigarette, cigar, e-cigarette, or smokeless-tobacco users, or multiple-tobacco-product users.
Measures: Respondents reported whether a healthcare professional had asked about tobacco use or recommended quitting in the past year. Analyses also considered healthcare visits and demographic, socioeconomic, and health characteristics.
Interpretation:
The supplied context describes the study rationale and methods but does not provide results; comparative screening or cessation-advice findings cannot be summarized from this material.
Limitations:
The provided context ends during the statistical-analysis section and contains no results or discussion.
The study relies on respondents’ reports of healthcare-provider interactions during the preceding year.
by Lauren R. Pacek, Min-Jeong Yang, Melissa Mercincavage, Monica J. Gilles, Kimberly Jordan-Casarona, Nicolette E. Garthe, Cristine D. Delnevo, Michael B. Steinberg
Optical analysis of resection-margin tissue identified tumor infiltration as the strongest contributor to predictions of where glioblastoma later recurred.
